Company news
Organon & Co. (NYSE:OGN) news
Organon & Co. news releases on 6ix. Latest, Mar 28, 2025: European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab)…
Press releases — page 2
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
March 28, 2025
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older
March 8, 2025